Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05908825Completed
Randomised, double-blind trial in photodamage, sponsored by Austin Institute for Clinical Research. Primary endpoints: Change in Product tolerability at Day 42 and Change in Product efficacy at Day 42. Started Jun 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05908825.